The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation

Documenti analoghi

• The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
  di: Bettoni, Fabiana, et al.
  Pubblicazione: (2019)
• Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients
  di: Lopes-Ramos, Camila Miranda, et al.
  Pubblicazione: (2014)
• Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen
  di: Habr-Gama, Angelita, et al.
  Pubblicazione: (2016)
• Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results
  di: Habr-Gama, Angelita, et al.
  Pubblicazione: (2004)
• Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: a meta-analysis based on individual patient data
  di: Verrijssen, An-Sofie, et al.
  Pubblicazione: (2019)